BlackRock Health Sciences Trust II 

$16.16
301
-$0.09-0.55%Past Week

Statistics

Day High
-
Day Low
-
52W High
17.81
52W Low
13.73
Volume
-
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
9.14%
Dividend
1.48

Upcoming

Dividends

9.14%Dividend Yield
Apr 26
$0.11
Mar 26
$0.11
Feb 26
$0.11
Jan 26
$0.11
Dec 25
$0.11
10Y Growth
N/A
5Y Growth
-2.08%
3Y Growth
-2.1%
1Y Growth
-20.63%

Earnings

1SepExpected
Q2 2020
Q4 2020
Q2 2021
Q4 2021
Q2 2022
-6.74
-1.89
2.97
7.82
Expected EPS
0
Actual EPS
-6.74

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XBMZX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Invesco Dorsey Wright Healthcare Momentum
PTH
Mkt Cap0
Invesco DWA Healthcare Momentum ETF focuses on healthcare momentum stocks, directly competing in the healthcare investment space.
iShares U.S. Healthcare
IYH
Mkt Cap0
iShares U.S. Healthcare ETF offers broad exposure to U.S. healthcare stocks, competing for similar investor interest.
Vanguard Health Care
VHT
Mkt Cap0
Vanguard Health Care ETF provides a broad exposure to the healthcare sector, similar to BMEZ's investment focus.
State Street Health Care Select Sector SPDR
XLV
Mkt Cap0
Health Care Select Sector SPDR Fund is a direct competitor, offering exposure to health care stocks within the S&P 500.
Fidelity MSCI Health Care Index
FHLC
Mkt Cap0
Fidelity MSCI Health Care Index ETF competes by tracking a large index of U.S. healthcare stocks.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF focuses on biotechnology, a key component of the healthcare sector, thus competing for similar investments.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF invests in biotechnology and pharmaceuticals, overlapping with BMEZ's investment interests.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF targets the biotech sector, directly competing with parts of BMEZ's portfolio.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, being a large healthcare and pharmaceutical company, represents a direct investment alternative in the healthcare sector.
Pfizer
PFE
Mkt Cap161.09B
Pfizer Inc., as a major player in pharmaceuticals, offers an alternative investment in the healthcare sector similar to BMEZ's focus.

About

BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
Show more...
CEO
Dr. Xiang Liu Ph.D.
Country
US

Listings

0 Comments

Share your thoughts

FAQ

What is BlackRock Health Sciences Trust II stock price today?
The current price of XBMZX is $16.16 USD — it has decreased by -0.55% in the past 24 hours. Watch BlackRock Health Sciences Trust II stock price performance more closely on the chart.
What is BlackRock Health Sciences Trust II stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange BlackRock Health Sciences Trust II stocks are traded under the ticker XBMZX.
Is BlackRock Health Sciences Trust II stock price growing?
XBMZX stock has risen by +3.04% compared to the previous week, the month change is a -1.34% fall, over the last year BlackRock Health Sciences Trust II has showed a +9.43% increase.
Does BlackRock Health Sciences Trust II pay dividends?
Yes, XBMZX dividends are paid monthly. The last dividend per share was 0.17 USD. As of today, Dividend Yield (FWD)% is 9.14%.
In which sector is BlackRock Health Sciences Trust II located?
BlackRock Health Sciences Trust II operates in the Health Care sector.
When did BlackRock Health Sciences Trust II complete a stock split?
BlackRock Health Sciences Trust II has not had any recent stock splits.
Where is BlackRock Health Sciences Trust II headquartered?
BlackRock Health Sciences Trust II is headquartered in New York, US.